Crossmark

Efficacy and safety of angiogenesis inhibitors plus immune checkpoint inhibitors in advanced soft tissue sarcoma: a real-world, single-center study

Published Online: 2023-02-28

Authors

Liu, Zengjun

Xu, Jing

Liu, Mengyao

Hu, Wenyu

Xu, Ni

Zhu, Dongyuan
Funding

Funding for this research was provided by:

Wu Jieping Medical Foundation (320.6750.2021-2-36)
License Information

Text and Data Mining valid from 2023-02-28

Version of Record valid from 2023-02-28
More Information

Article History

Received: 8 January 2023

Accepted: 22 February 2023

First Online: 28 February 2023

Competing interests

: The authors declare no competing interests.

Document is current